CompletedPhase 2NCT00268788
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Studying Multifocal motor neuropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Aarhus
- Principal Investigator
- Henning Andersen, MD, DMScAarhus University Hospital
- Intervention
- Subcutaneous immunoglobulin(drug)
- Enrollment
- 10 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2005 – 2008
Study locations (1)
- Aarhus University Hospital, Department of Neyrology, Aarhus, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00268788 on ClinicalTrials.govOther trials for Multifocal motor neuropathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06742190A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathyargenx
- RECRUITINGPHASE2NCT06537999A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyDianthus Therapeutics
- ACTIVE NOT RECRUITINGNCT05988073A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathyargenx
- ACTIVE NOT RECRUITINGPHASE2NCT05405361A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathyargenx